| BNP | Brain natriuretic peptide | PAH | Pulmonary arterial hypertension |
| BPA | Ballon pulmonary angioplasty | PAP | Pulmonary arterial pressure |
| cGMP | Cyclic guanosine monophosphate | PAWP | Pulmonary arterial wedge pressure |
| CPET | Cardiopulmonary exercise test | PEA | Pulmonary endarterectomy |
| CTEPH | Chronic thromboembolic pulmonary hypertension | PDE5i | Phosphodiesterase type 5 inhibitors (PDE5i) |
| CT | Computed tomography | PDGF | Platelet-derived growth factor |
| DOAC | Direct oral anticoagulation | PH | Pulmonary hypertension |
| EF | Ejection fraction | PVR | Pulmonary vascular resistance |
| ERAs | Endothelin receptor antagonists | RHC | Right heart catheterization |
| GCs | Guanylic cyclase stimulator | RV | Right ventricle |
| HF | Heart Failure | SGc | Soluble guanylate cyclase |
| MWD | Minute walking distance | TGF-β | Transforming growth factor-β |
| NO | Nitric oxide | TRV | Tricuspid regurgitation velocity |
| NT-proBNP | N-terminal pro brain natriuretic peptide | WU | Wood Units |